Erin L.Shencopp

Partner

(T) 1.312.269.4276 (F) 1.312.782.8585

Erin Shencopp counsels and defends clients in all antitrust aspects of their strategic transactions and significant business decisions. She has defended multibillion dollar mergers in investigations by the U.S. Department of Justice and Federal Trade Commission, litigated merger cases in federal court, and defended clients in government investigations and private litigation alleging price-fixing, monopolization, tying, and other anticompetitive conduct. In 2017 and 2018, Erin was named to Who's Who Legal: Competition — Future Leaders.

Erin has experience in a broad range of industries, including medical devices, pharmaceuticals, health care services, consumer products, telecommunications, mining, and chemicals. Representative clients include Aetna, Baxter International, Boehringer Ingelheim, Cardinal Health, AB Electrolux, and Potash Corporation of Saskatchewan. Erin's work includes counseling clients at every stage of a deal, including premerger planning, regulatory filings, investigations, and litigation. She also frequently advises clients on a variety of antitrust issues, including competitor and vertical collaborations, information sharing, distribution arrangements, and pricing and contracting practices.

In addition, Erin is actively involved in pro bono work. She has successfully tried an asylum case and has argued a habeas corpus petition before the U.S. Court of Appeals for the Sixth Circuit. She also contributes to several antitrust law publications and is a member of Bryn Mawr College's President's Advisory Council.

Experience

  • PotashCorp combines with Agrium in $38 billion merger-of-equalsJones Day advised PotashCorp in its $38 billion all-stock merger-of-equals with Agrium.
  • Aetna attempts acquisition of HumanaJones Day represented Aetna Inc. as antitrust counsel in its attempted $37 billion acquisition of fellow health insurer Humana Inc.
  • naviHealth acquires CuraspanJones Day advised naviHealth Inc., a Cardinal Health company, in its acquisition of Curaspan Health Group Inc., a privately held leading provider of care transition tools for hospitals and post-acute healthcare providers.
  • Electrolux attempts acquisition of GE appliances businessJones Day represented Swedish appliance maker AB Electrolux as antitrust and labor counsel in its attempted $3.3 billion acquisition of the appliances business of General Electric.
  • CVS Caremark prevails in Second Circuit appeal of summary judgment dismissing hundreds of Robinson-Patman Act claimsThe Second Circuit affirmed summary judgment dismissing all claims by pharmacies against Jones Day client CVS Caremark Corporation and one other defendant, following the settlement by the other five defendants remaining in the case.
  • Cardinal Health acquires The Harvard Drug Group for $1.115 billionJones Day advised Cardinal Health in its acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications, and related products to retail, institutional, and alternate care customers from Court Square Capital Partners for $1.115 billion.
  • FTD acquires Liberty Interactive's Provide Commerce floral and gifting businesses for $430 millionJones Day advised FTD Companies, Inc. in the acquisition of Liberty Interactive Corporation's Provide Commerce floral and gifting businesses for $430 million.
  • 3D Systems wins Federal Circuit appeal affirming summary judgment dismissing all antitrust and state law claimsOn April 18, 2014, the Federal Circuit affirmed summary judgment dismissing all antitrust and state law claims against Jones Day client 3D Systems, Inc., holding that the plaintiff failed to present evidence sufficient to support a jury finding in favor of plaintiff on the issue of the definition of the relevant market.
  • Potash Corporation settles antitrust class actionsJones Day defended Potash Corporation of Saskatchewan, Inc. and PCS Sales (USA), Inc. against class actions alleging that they and other potash producers conspired to fix potash prices, to divide markets, to restrict supply, and to fraudulently conceal the conspiracy, all in violation of federal and various state antitrust laws.
  • Tibetan refugee wins asylumOur client, a Tibetan Buddhist, was arrested, beaten, and detained for two days in a tiny cell with little food or water because the client distributed leaflets supporting the Dalai Lama and Tibetan sovereignty at a religious celebration at a monastery near the client's home.
  • Boehringer Ingelheim Pharmaceuticals obtains dismissal of antitrust claims alleging sham litigation, brought by direct and indirect purchasersOn behalf of Boehringer Ingelheim Pharmaceuticals, Inc., Jones Day obtained dismissal of direct and indirect purchaser class actions in cases alleging that Boehringer brought sham litigation to maintain an unlawful monopoly.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.